The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

A.N. Bogolepova

Pirogov Russian National Research Medical University;
Federal Center of Brain Research and Neurotechnologies of the Federal Medical Biological Agency

Features of pharmacotherapy of vascular cognitive impairment in the elderly

Authors:

A.N. Bogolepova

More about the authors

Views: 580

Downloaded: 2


To cite this article:

Bogolepova AN. Features of pharmacotherapy of vascular cognitive impairment in the elderly. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2023;123(9):15‑20. (In Russ.)
https://doi.org/10.17116/jnevro202312309115

Recommended articles:
Cere­brolysin in the treatment of cognitive impairment. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2023;(3):20-25
Features of treatment and reha­bilitation of COVID-19 patients with ischemic stroke. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2023;(3-2):76-84
Clinico-psychological profile and life quality of patients with post-COVID syndrome. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2023;(4):53-58
Predictors of the effi­cacy of non-drug treatments for non-dementia vascular cognitive impairment. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2023;(5):83-88

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation



We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.